Logo image of CRTD

CREATD INC (CRTD) Stock Fundamental Analysis

NASDAQ:CRTD - Nasdaq - US2252651078 - Common Stock - Currency: USD

0.195  -0.18 (-48.11%)

After market: 0.2 +0.01 (+2.56%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CRTD. CRTD was compared to 70 industry peers in the Interactive Media & Services industry. Both the profitability and financial health of CRTD have multiple concerns. CRTD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CRTD has reported negative net income.
CRTD Yearly Net Income VS EBIT VS OCF VS FCFCRTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA -362.19%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRTD Yearly ROA, ROE, ROICCRTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -2K -4K

1.3 Margins

Industry RankSector Rank
OM -593.73%
PM (TTM) -659.9%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRTD Yearly Profit, Operating, Gross MarginsCRTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -5K -10K -15K

More info and screens

1

2. Health

2.1 Basic Checks

CRTD does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRTD has more shares outstanding than it did 1 year ago.
The debt/assets ratio for CRTD has been reduced compared to a year ago.
CRTD Yearly Shares OutstandingCRTD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M
CRTD Yearly Total Debt VS Total AssetsCRTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -29.40, we must say that CRTD is in the distress zone and has some risk of bankruptcy.
CRTD has a Debt/Equity ratio of -0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.01
Debt/FCF N/A
Altman-Z -29.4
ROIC/WACCN/A
WACC11.29%
CRTD Yearly LT Debt VS Equity VS FCFCRTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 5M -5M -10M -15M -20M

2.3 Liquidity

A Current Ratio of 0.27 indicates that CRTD may have some problems paying its short term obligations.
CRTD has a Quick Ratio of 0.27. This is a bad value and indicates that CRTD is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.23
CRTD Yearly Current Assets VS Current LiabilitesCRTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.35% over the past year.
Looking at the last year, CRTD shows a very strong growth in Revenue. The Revenue has grown by 141.63%.
CRTD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.22% yearly.
EPS 1Y (TTM)55.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.67%
Revenue 1Y (TTM)141.63%
Revenue growth 3Y277.38%
Revenue growth 5Y81.22%
Sales Q2Q%67.47%

3.2 Future

Based on estimates for the next years, CRTD will show a very negative growth in Earnings Per Share. The EPS will decrease by -23.02% on average per year.
The Revenue is expected to grow by 148.15% on average over the next years. This is a very strong growth
EPS Next Y-51.33%
EPS Next 2Y-23.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year146.31%
Revenue Next 2Y148.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRTD Yearly Revenue VS EstimatesCRTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CRTD Yearly EPS VS EstimatesCRTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRTD. In the last year negative earnings were reported.
Also next year CRTD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRTD Price Earnings VS Forward Price EarningsCRTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.1
CRTD Per share dataCRTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

CRTD's earnings are expected to decrease with -23.02% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.02%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRTD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CREATD INC

NASDAQ:CRTD (9/6/2022, 8:00:01 PM)

After market: 0.2 +0.01 (+2.56%)

0.195

-0.18 (-48.11%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)08-11 2022-08-11
Earnings (Next)11-14 2022-11-14
Inst Owners0.1%
Inst Owner Change0%
Ins Owners102.13%
Ins Owner Change0%
Market Cap647.39K
Analysts0
Price TargetN/A
Short Float %0.12%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -0.1
EPS(TTM)-2.25
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.67
BVpS-0.72
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -362.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -593.73%
PM (TTM) -659.9%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity -0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.23
Altman-Z -29.4
F-Score4
WACC11.29%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.67%
EPS Next Y-51.33%
EPS Next 2Y-23.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)141.63%
Revenue growth 3Y277.38%
Revenue growth 5Y81.22%
Sales Q2Q%67.47%
Revenue Next Year146.31%
Revenue Next 2Y148.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A